USBOX | VFINX | USBOX / VFINX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 40 years | 48 years | - |
Gain YTD | 1.915 | 2.006 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 337M | 1.35T | 0% |
Annual Yield % from dividends | 0.31 | 1.24 | 25% |
Returns for 1 year | 9.43 | 25.53 | 37% |
Returns for 3 years | 5.04 | 31.14 | 16% |
Returns for 5 years | 25.30 | 80.24 | 32% |
Returns for 10 years | 38.87 | 197.00 | 20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MCRTX | 51.08 | 0.74 | +1.47% |
Morgan Stanley Insight R6 | |||
NWAYX | 15.44 | 0.12 | +0.78% |
Nationwide GQG US Quality Eq Eagle | |||
GHAAX | 38.49 | 0.19 | +0.50% |
VanEck Global Resources Fund A | |||
LMGTX | 55.04 | 0.14 | +0.26% |
ClearBridge International Growth C | |||
SHPCX | 13.05 | -0.06 | -0.46% |
Saratoga Health & Biotechnology C |